FGF23 and left ventricular hypertrophy: In our previous study, we demonstrated that serum FGF23 levels were positively and negatively associated with, respectively, left ventricular hypertrophy (LVH) and systolic dysfunction among cardiology inpatients; owing to the relatively small population, however, these associations could not be statistically assessed according to CKD stage [16].